OPFM
ENFN

Optimus Prime Fund Management’s Enfusion, Inc. ENFN Stock Holding History

Optimus Prime Fund Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,500
Closed -$130K – 55
2022
Q3 		$130K Hold
10,500
– – 0.02% 55
2022
Q2 		$107K Hold
10,500
– – 0.01% 60
2022
Q1 		$134K Buy
+10,500
New +$160K 0.01% 60

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Optimus Prime Fund Management's ENFN Position: Q4 2022 in Review

Optimus Prime Fund Management sold out of Enfusion, Inc. (ENFN) in Q4 2022, closing a stake of 10,500 shares — an estimated $130K sold.

Optimus Prime Fund Management first reported a position in ENFN in Q1 2022 and held it in 3 quarters. The position peaked at $134K in Q1 2022. 74 funds tracked by Wall St. Rank hold ENFN as of Q4 2022.

  • Optimus Prime Fund Management reported no remaining Enfusion, Inc. position as of Q4 2022 after selling out during the quarter.
  • Optimus Prime Fund Management sold 10,500 Enfusion, Inc. shares in Q4 2022, an estimated $130K.
  • Optimus Prime Fund Management first reported a position in Enfusion, Inc. in Q1 2022 and held it in 3 quarters.
  • Optimus Prime Fund Management's Enfusion, Inc. position peaked at $134K in Q1 2022.
  • 74 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2022.

Based on Optimus Prime Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.